SCHEMBL11301763

SCHEMBL11301763

COc1ccc(C(=O)N(c2ccc(C(=O)NO)cc2)C2CCNC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 1/20 0.51
▸ CA2 P00918 1/20 0.51
▸ CHRM2 P08172 1/20 0.45
▸ CHRM3 P20309 1/20 0.45
▸ CYP2D6 P10635 7/20 0.45
▸ SLC6A2 P23975 4/20 0.45
▸ SLC6A4 P31645 4/20 0.45
▸ SLC6A3 Q01959 4/20 0.45
▸ KCNH2 Q12809 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ ADAM17 P78536 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ MC4R P32245 1/20 0.41
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11302583 0.86 SLC6A2 (0.53) CA1CHRM2CHRM3CYP2D6SLC6A2
SCHEMBL11305529 0.85 SLC6A4 (0.46) CYP2D6SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL9429122 0.74 TRPM8 (0.51) CHRM2CHRM3CYP2D6SLC6A2SLC6A4
SCHEMBL11300778 0.74 HDAC1 (0.49) CHRM2CHRM3CYP2D6SLC6A2SLC6A4
SCHEMBL15480658 0.73 CA1 (0.70) CA1CA2LMNAALOX15ALOX12
SCHEMBL11578352 0.73 SLC6A2 (0.66) CHRM2CHRM3CYP2D6SLC6A2SLC6A4
SCHEMBL11306334 0.72 HDAC1 (0.45) CA1CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL11300763 0.72 HDAC8 (0.42) KDM4EMEN1LMNAALOX15ALOX12
SCHEMBL28628582 0.72 MCHR1 (0.50) CA1CA2SLC6A2SLC6A4KCNH2
SCHEMBL942259 0.71 CA1 (1.00) CA1CA2CYP2D6MEN1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-B1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER HOFFMANN LA ROCHE (CH) 2014-10-22 — — EP claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback